Further, silencing HMGA1 disrupts oncogenic properties (proliferation and clonogenicity), while reexpression of ASCL2 partially rescues oncogenic phenotypes in HMGA1-depleted human colon cancer cells. The gene discussed is ASCL2; the disease is malignant colon neoplasm.